13F Filings History of Antara Capital LP
- Latest 13F filing
- Q4 2025 - 17 Feb 2026
- Latest reported 13F value
- $30,189
- Largest 13F holdings
-
ASBP ASBPW
- Form 13F summary
-
- Antara Capital LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Antara Capital LP reported 2 equity holdings with a total reported market value of $30,189 for Q4 2025.
- Manager signature
- Jeremy Heckerling - CCO
- Manager location
- New York, NY
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Antara Capital LP with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q4 2025
Latest value
$30,189
Quarter delta
-$459,994
Accepted
17 Feb 2026, 16:33
Rows shown
1-25 of 30
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 2 | $30,189 | $0 | -$442,176 | -$442,176 | ASBP, ASBPW | 13F-HR | 17 Feb 2026, 16:33 |
| Q3 2025 | 3 | $490,183 | +$48,007 | -$1,437,298 | -$1,389,291 | CURR, ASBP, ASBPW | 13F-HR | 14 Nov 2025, 13:02 |
| Q2 2025 | 2 | $1,119,572 | +$1,119,572 | -$88,818 | +$1,030,754 | CURR, RZLV | 13F-HR | 14 Aug 2025, 16:35 |
| Q1 2025 | 12 | $88,818 | +$14,064 | -$48,707,325 | -$48,693,261 | THCH, XAGE, PITAW, LDTCW, ECXWW | 13F-HR | 15 May 2025, 11:38 |
| Q4 2024 | 20 | $48,884,297 | +$43,051,870 | -$18,050,408 | +$25,001,462 | WESTERN DIGITAL CORP, VENTAS RLTY LTD PARTNERSHIP, IGT, UBER TECHNOLOGIES INC, BUR | 13F-HR | 14 Feb 2025, 11:25 |
| Q3 2024 | 24 | $17,499,847 | +$13,780,079 | -$57,237,118 | -$43,457,039 | EDR, INVZ, IGT, INVZW, BUR | 13F-HR | 14 Nov 2024, 13:52 |
| Q2 2024 | 25 | $60,998,894 | +$50,658,050 | -$29,510,830 | +$21,147,220 | CHPT, ACI, IGT, BUR, KR | 13F-HR | 14 Aug 2024, 16:11 |
| Q1 2024 | 25 | $43,010,761 | +$33,280,441 | -$12,283,090 | +$20,997,351 | SHY, CHPT, UHG, INVZW, ACI | 13F-HR | 14 May 2024, 15:05 |
| Q4 2023 | 25 | $26,098,787 | +$11,459,789 | -$46,824,700 | -$35,364,911 | SAVE, UHG, INVZW, INVZ, ALCE | 13F-HR | 14 Feb 2024, 11:29 |
| Q3 2023 | 38 | $58,924,187 | +$15,599,738 | -$24,928,339 | -$9,328,601 | HCVI, CLIN, PEGR, UHG, INVZW | 13F-HR | 14 Nov 2023, 13:25 |
| Q2 2023 | 45 | $80,954,069 | +$14,383,269 | -$289,121,004 | -$274,737,735 | INVZ, UHG, CLIN, PEGR, INVZW | 13F-HR | 14 Aug 2023, 10:54 |
| Q1 2023 | 54 | $370,540,926 | +$113,658,514 | -$548,502,626 | -$434,844,112 | SAVE, NKLA, ACI, BKI, UHG | 13F-HR | 12 May 2023, 16:17 |
| Q4 2022 | 88 | $825,505,000 | +$312,779,141 | -$370,599,951 | -$57,820,810 | SAVE, VMW, BKI, SIMO, ATVI | 13F-HR | 13 Feb 2023, 16:45 |
| Q3 2022 | 140 | $903,779,000 | +$515,974,766 | -$608,855,894 | -$92,881,128 | ATVI, CLR, INVZ, SAVE, CLOVIS ONCOLOGY INC | 13F-HR | 14 Nov 2022, 16:06 |
| Q2 2022 | 221 | $967,121,000 | +$167,894,424 | -$347,056,095 | -$179,161,671 | CLOVIS ONCOLOGY INC, DRAFTKINGS INC NEW, UBER TECHNOLOGIES INC, INVZ, MICROSTRATEGY INC | 13F-HR | 15 Aug 2022, 15:58 |
| Q1 2022 | 224 | $1,278,315,000 | +$587,510,464 | -$148,783,011 | +$438,727,453 | DRAFTKINGS INC, SEA LTD, CLOVIS ONCOLOGY INC, DISH NETWORK CORPORATION, UBER TECHNOLOGIES INC | 13F-HR | 16 May 2022, 16:12 |
| Q4 2021 | 190 | $819,731,000 | +$521,934,094 | -$146,354,255 | +$375,579,839 | CLOVIS ONCOLOGY INC, SEA LTD, VICI, IGT, UBER TECHNOLOGIES INC | 13F-HR | 14 Feb 2022, 10:19 |
| Q3 2021 | 137 | $508,294,000 | +$278,947,969 | -$274,473,259 | +$4,474,710 | CLOVIS ONCOLOGY INC, INVZ, SEA LTD, VICI, SLVRU | 13F-HR | 15 Nov 2021, 10:50 |
| Q2 2021 | 153 | $547,588,000 | +$410,793,105 | -$237,996,649 | +$172,796,456 | INVZ, CLOVIS ONCOLOGY INC, DELL, DISH NETWORK CORPORATION, SRNG | 13F-HR | 16 Aug 2021, 16:44 |
| Q1 2021 | 86 | $384,126,000 | +$329,032,532 | -$26,944,948 | +$302,087,584 | Clovis Oncology Inc, PARA, SRNGU, JD, TERN | Restatement | 22 Sep 2021, 18:52 |
| Q4 2020 | 11 | $37,683,000 | +$23,307,000 | -$197,072,525 | -$173,765,525 | USA Technologies Inc, IVA, BNED, INVA, Omeros Corp | 13F-HR | 16 Feb 2021, 16:58 |
| Q3 2020 | 31 | $244,933,000 | +$137,830,663 | -$140,935,853 | -$3,105,190 | Tilray Inc, TIF, IAC, Clovis Oncology Inc, RBACU | 13F-HR | 16 Nov 2020, 11:31 |
| Q2 2020 | 1 | $48,461,000 | $0 | $0 | $0 | Tilray Inc | New Holdings | 18 Aug 2020, 10:39 |
| Q2 2020 | 23 | $248,614,000 | +$126,606,517 | -$6,549,521 | +$120,056,996 | IAC, Tilray Inc, TIF, Clovis Oncology Inc, ERI | 13F-HR | 14 Aug 2020, 10:10 |
| Q1 2020 | 16 | $100,230,000 | +$63,724,042 | -$60,919,000 | +$2,805,042 | Tilray Inc, IAC, TIF, Clovis Oncology Inc, CPAA | 13F-HR | 14 May 2020, 14:29 |